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Targeted Disruption of the Melanocortin-4
Receptor Results in Obesity in Mice
Dennis Huszar,* Catherine A. Lynch,* mechanisms by which body weight and energy expendi-
ture are regulated. However, it is clear that the controlVictoria Fairchild-Huntress,*
of body weight is a complex process that will likelyJudy H. Dunmore,* Qing Fang,*
involve the interplay of additional, as yet undefined, neu-Lucy R. Berkemeier,* Wei Gu,*
ral circuits and molecular mechanisms (Friedman andRobert A. Kesterson,† Bruce A. Boston,‡
Leibel, 1992; Campfield et al., 1996; Spiegelman andRoger D. Cone,† Francoise J. Smith,§
Flier, 1996). The existence of one such pathway, involv-L. Arthur Campfield,§ Paul Burn,§
ing signaling via neural melanocortin receptors, hasand Frank Lee*
been hypothesized on the basis of studies of the action*Millennium Pharmaceuticals, Inc.
of the agouti pigmentation factor (Lu et al., 1994).640 Memorial Drive
Agouti, a 131 amino acid secreted protein expressedCambridge, Massachusetts 02139
exclusively within the hair follicle, regulates the synthe-†Vollum Institute for Advanced Biomedical Research
sis of brown-black (eumelanin) and yellow-red (phaeo-‡Department of Pediatrics
melanin) pigment to produce the wild-type (agouti) pat-Oregon Health Sciences University
tern of coat coloration: black hairs with a subapicalPortland, Oregon 97201
yellow band (Bultman et al., 1992; Miller et al., 1993;§Hoffmann–La Roche, Inc.
reviewed in Silvers, 1979). Agouti acts in a paracrineDepartment of Metabolic Diseases
fashion on melanocytes (Silvers and Russell, 1955) toNutley, New Jersey 07110
induce a switch from eumelanin to phaeomelanin syn-
thesis by antagonism of the melanocortin-1 receptor
(MC1-R) (Lu et al., 1994), also known as the melanocyte-
stimulating hormone receptor (MSH-R), a G protein–Summary
coupled, seven-transmembrane receptor (Mountjoy et
al., 1992; Chhajlani and Wikberg, 1992; Robbins et al.,The melanocortin-4 receptor (MC4-R) is a G protein–
1993).coupled, seven-transmembrane receptor expressed in
Dominant alleles of the agouti locus resulting in wide-the brain. Inactivation of this receptor by gene tar-
spread ectopic expression of agouti give rise to a pleio-geting results in mice that develop a maturity onset
tropic obesity syndrome referred to as the obese yellow,obesity syndrome associated with hyperphagia, hy-
or agouti, syndrome (Bultman et al., 1992; Michaud etperinsulinemia, and hyperglycemia. This syndrome re-
al., 1993; Miller et al., 1993; Duhl et al., 1994; Michaudcapitulates several of the characteristic features of the
et al., 1994a; 1994b). The best characterized and mostagouti obesity syndrome, which results from ectopic
dominant of the allele series are the lethal yellow (Ay)expression of agouti protein, a pigmentation factor
and viable yellow (Avy) mutants. Obese yellow mice arenormally expressed in the skin. Our data identify a
characterized by maturity-onset obesity (in contrast to
novel signaling pathway in the mouse for body weight
the early-onset obesity of ob and db mice), hyperinsulin-
regulation and support a model in which the primary emia, hyperglycemia in males, and yellow coat color
mechanism by which agouti induces obesity is chronic (reviewed by Yen et al., 1994). The mice are hyperphagic
antagonism of the MC4-R. (Frigeri et al., 1988; Shimizu et al., 1989) and display
increased rates of hepatic lipogenesis (Yen et al., 1976b)
and decreased rates of lipolysis in adipocytes (Yen etIntroduction
al., 1970). The increased adiposity of dominant agouti
mutants is primarily due to fat cell hypertrophy, as isOver the past few years, there has been considerable
true of most human forms of obesity, rather than the
progress in identification and characterization of the
more prevalent hyperplasia characteristic of ob and db
mutations underlying five monogenic murine models of
mice (Johnson and Hirsch, 1972). In addition, obese
obesity: obese (ob), diabetes (db), fat (fat), tubby (tub), yellow mice are unique among rodent obesity models
and obese yellow (e.g., Ay). In particular, cloning of the in exhibiting a slight increase in linear growth, in contrast
ob and db genes has led to identification of a signaling to ob and db mice, which are somewhat shorter than
system that monitors the status of energy stores in the their wild-type littermates (Heston and Vlahakis, 1962;
body. The ob gene product, leptin, is a circulating pro- Wolff, 1963).
tein secreted by adipose tissue that communicates body The dominant agouti alleles that give rise to obesity
fat content to the brain through the OB receptor (OB-R), result in constitutive deregulated synthesis of wild-type
the product of the db gene. The OB-R is a member of agouti protein within the hair follicle, accounting for the
the class 1 cytokine receptor family expressed in the yellow coat color, and ectopic expression of agouti
hypothalamus and other tissues (Zhang et al., 1994; throughout the animal, presumably accounting for the
Campfield et al., 1995; Halaas et al., 1995; Pelleymounter other characteristics of the pleiotropic obesity syn-
et al., 1995; Tartaglia et al., 1995; Baumann et al., 1996; drome (Bultman et al., 1992; Michaud et al., 1993; Miller
Chen et al., 1996; Chua et al., 1996; Ghilardi et al., 1996; et al., 1993; Duhl et al., 1994). That this phenotype is
Lee et al., 1996). directly related to ectopic expression of agouti, rather
The identification of the leptin signaling pathway rep- than to other potential effects of the various agouti pro-
moter mutations, is supported by the demonstrationresents a significant advance in the elucidation of the
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that transgenic mice ectopically expressing agouti from
ubiquitous promoters recapitulate the obese hyperinsu-
linemic phenotype (Klebig et al., 1995; Perry et al., 1995).
Furthermore, the obesity phenotype is not dependent
on synthesis of yellow pigment, or disruption of MC1-R
function, since Avy mice carrying the gain of function
MC1-R mutation somber (Eso) are black yet still obese
(Wolff et al., 1978) and yellow e/e mice, which lack
MC1-R function (Robbins et al., 1993), are not obese
(Searle, 1968).
One hypothesis for the mechanism by which ectopic
agouti expression induces obesity is aberrant antago-
nism of melanocortin receptors expressed in regions of
the brain known to be involved in regulating feeding (Lu
et al., 1994; Mountjoy et al., 1994). In addition to the
MC1-R, four other members of the melanocortin recep-
tor family have been identified: the MC2-R (Mountjoy et
al., 1992), MC3-R (Gantz et al., 1993a; Roselli-Rehfuss
et al., 1993), MC4-R (Gantz et al., 1993b; Mountjoy et
al., 1994), and MC5-R (Chhajlani et al., 1993; Gantz et
al., 1994; Griffon et al., 1994; Labbe et al., 1994). All
are G protein–coupled receptors that activate adenylyl
cyclase and bind ligands collectively referred to as the
melanocortins (e.g., adrenocorticotrophin [ACTH] and
the a-, b-, and g-melanocyte–stimulating hormones) de-
rived from the precursor proopiomelanocortin (POMC).
The MC2-R is the ACTH receptor, expressed primarily
in the adrenal cortex (Mountjoy et al., 1992). The MC3-R
and MC4-R are neural melanocortin receptors. The
MC3-R is expressed in the brain in regions of the hypo-
thalamus and limbic system, as well as in the placenta
Figure 1. Deletion of the Mouse MC4-Rand gut (Gantz et al., 1993a; Roselli-Rehfuss et al., 1993),
(A) Schematic diagrams and partial restriction maps of the MC4-Rwhereas expression of the MC4-R is restricted primarily
locus, the MC4-R targeting vector, and the predicted structure ofto the brain, where it is widely expressed (Gantz et al.,
the MC4-R locus following homologous recombination with the tar-
1993b; Mountjoy et al., 1994; reviewed in Low et al., geting vector. The open box represents MC4-R coding sequences,
1994). The MC5-R, on the other hand, is widely ex- the closed box is the 200 bp SphI–SacI flanking probe used to
identify the targeted MC4-R locus, and the shaded box indicatespressed at low levels throughout the body (Gantz et al.,
the PGK–neo expression cassette. The arrows indicate the direction1994; Griffon et al., 1994; Labbe et al., 1994). To test for
of transcription.agouti antagonism, Lu et al. (1994) expressed melano-
(B) Autoradiogram of a Southern blot analysis of tail DNA from F2
cortin receptors in 293 cells and assayed the ability of progeny. Genomic DNA was digested with ApaI or NcoI, as indi-
agouti to inhibit a-MSH–induced stimulation of adenylyl cated, and hybridized with the radiolabeled probe shown in (A), then
stripped and rehybridized with a radiolabeled probe consisting ofcyclase activity. The results demonstrated that agouti
the human MC4-R coding sequence. 1/1, 1/2, and 2/2 denotewas a high affinity antagonist of both the MC1 and MC4
DNA from wild-type, heterozygous, and homozygous F2 littermates,receptors in vitro, but not of the MC3 or MC5 receptors,
respectively.
suggesting that agouti antagonism of the MC4-R could
be the cause of the agouti obesity syndrome.
(Figure 1A). A targeting vector was designed to deleteTo evaluate whether signaling via the MC4-R plays a
virtually all MC4-R coding sequence following homolo-
role in the regulation of body weight, mice lacking the
gous recombination with the locus in embryonic stem
receptor were generated by gene targeting in embryonic
cells. As shown in Figure 1A, the vector consists of a
stem (ES) cells. Our results show that absence of the
total of approximately 4.5 kb of strain 129/Sv mouse
MC4-R produces an obesity syndrome strikingly remi- genomic DNA flanking a deletion of 1.5 kb. This deletion
niscent of the agouti syndrome, defininga novel function extends from the NcoI site located approximately 20
for the MC4-R in the regulation of energy balance and nucleotides downstream of the MC4-R initiation codon
supporting aberrant antagonism of the MC4-R as the to the HindIII site situated approximately 0.5 kb 39 of
primary cause of the agouti obesity syndrome. the gene. The deleted MC4-R sequences have been
replaced by the neo gene under the control of the phos-
phoglycerate kinase-1 (PGK-1) promoter.
Results A total of 809 G418-resistant colonies were screened
for homologous recombination by Southern blot hybrid-
Generation of MC4-R–Deficient Mice ization of ApaI-digested genomic DNA with the flanking
The murine MC4-R gene consists of approximately 1 probe shown in Figure 1A. One clone showed the pre-
dicted 7.6 kb targeted ApaI DNA fragment in additionkb of coding sequence contained within a single exon
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to the expected 2.2 kb wild-type fragment. Injection of controls. Male homozygotes and heterozygotes are ap-
proximately 8% and 2.5% longer than controls, respec-this clone into C57BL/6J blastocysts produced several
male chimeras that, when bred to C57BL/6J females, tively.
transmitted the targeted MC4-R allele to their F1 129/
B6 offspring. F1 heterozygotes were interbred and their Food Consumption
offspring genotyped by Southern blot hybridization of To determine whether food consumption was increased
ApaI- or NcoI-digested tail DNA with the flanking probe. in mice lacking the MC4-R, homozygous mutant females
As described above, ApaI digestion generates a wild- and wild-type F2 controls weremonitored for food intake
type fragment of 2.2 kb and a targeted fragment of 7.6 over a two-week period. Ay mutants, on a C57BL/6J
kb (note that this 7.6 kb is distinct from a background background, and C57BL/6J controls were also moni-
band of slightly lower molecular weight that is present tored. As previously documented (Frigeri et al., 1988;
in all samples; see Figure 1B). NcoI digestion generates Shimizu et al., 1989), Ay mice were hyperphagic, eating
two wild-type fragments of 2.7 and 2.9 kb, since the 36% more than C57BL/6J controls. Absence of the
NcoI site is situated within the sequences recognized MC4-R also resulted in a significant increase (46%) in
by the flanking probe (Figures 1A and 1B). The 2.7 kb food consumption over wild-type F2 controls (Figure 4).
NcoI fragment represents genomic sequences ex-
tending 39 of the probe that are unaffected by MC4-R
Serum Glucose, Insulin, and Leptin Concentrationstargeting, whereas the 2.9 kb band includes the MC4-R
Blood was collected from MC4-R–deficient mice andgene sequences. Following targeting, this latter frag-
wild-type controls over three time intervals (4–8 weeks,ment is reduced toa 2 kb banddiagnostic of the mutated
10–14 weeks, and 17–23 weeks) and serum assayed forMC4-R allele. As shown in Figure 1B, heterozygous in-
glucose and insulin levels. Serum glucose levels weretercrosses produced homozygous mutant, heterozy-
essentially unchanged in females heterozygous or ho-gous, and wild-type F2 progeny. To verify deletion of
mozygous for MC4-R deletion, but both heterozygousthe MC4-R gene in homozygous mutants, the filters were
and homozygous males were hyperglycemic (Figuresstripped and rehybridized with an MC4-R probe. No
5A and 5B). This was first evident for homozygous malesMC4-R hybridization was detected in homozygous mu-
at the 10–14 week interval, at which time glucose levelstant mice, whereas the predicted 2.2 kb and 5.1 kb ApaI
were elevated over 2-fold above controls, to 390 mg/dl,bands (ApaI cuts within the MC4-R gene generating two
but heterozygous mutants showed only a slight eleva-MC4-R–containing fragments; see Figure 1A) and 2.9 kb
tion of serum glucose at this age. By 17–23 weeks ofNcoI fragment were observed in both heterozygous and
age, both heterozygous and homozygous male mutantwild-type littermates (Figure 1B).
mice showed a doubling of normal serum glucose levels
(334 and 361 mg/dl, respectively) relative to controls
(156 mg/dl).Body Weight and Size of MC4-R–Deficient Mice
F2 animals were maintained on a chow diet ad libitum Both male and female mutant mice were hyperinsulin-
emic (Figures 5C and 5D). Inceases in insulin levels byand their weights monitored regularly. The weights of
MC4-R–deficient mice and their wild-type littermates 9-fold and 5-fold were evident in thesera of homozygous
mutant females and males, respectively, at 4–8 weekswere largely indistinguishable for the first 4 weeks of
life. However, by approximately 5 weeks of age, most of age. These levels increased dramatically over time,
such that by 17–23 weeks of age the mean concentrationof the homozygous mutants, both males and females,
were heavier than their wild-type siblings of the same of insulin in the serum of homozygous mutant females
was approximately 65 ng/ml, and for males approxi-sex, and by 7 weeks of age all of the null mutants were
heavier than the controls (Figures 2A and 2C). By 15 mately 130 ng/ml, representing appoximately 60- and
14-fold increases, respectively, over insulin levels in F2weeks of age, homozygous mutant females were on
average twice as heavy as their wild-type siblings, while wild-type controls. Heterozygous mutants were also hy-
perinsulinemic, although less so than homozygous mu-homozygous mutant males were approximately 50%
heavier than wild-type controls. By about 24 weeks of tants. For both male and female heterozygotes, a signifi-
cant difference in insulin levels relative to controls wasage the weight of female null mice averaged approxi-
mately 63 grams (n 5 3), and males averaged approxi- first observed at the 10–14 week interval. By 17–23
weeks, mean insulin levels of heterozygotes were ele-mately 65 grams (n 5 8). Mice heterozygous for MC4-R
deletion showed a weight gain intermediate to that seen vated to approximately 10 ng/ml (females) and 85 ng/
ml (males).in wild-type and homozygous mutant sibs (Figures 2B
and 2D), demonstrating a gene dosage effect of MC4-R In addition to glucose and insulin, serum leptin and
corticosterone levels were also determined. Leptin lev-ablation on body weight regulation.
To determine whether mice lacking the MC4-R exhib- els are elevated in Ay mice (Maffei et al., 1995; Mizuno
et al., 1996), indicating that the syndromedoes not resultited alterations in linear growth, body length (naso–anal)
measurements of F2 progeny were taken at approxi- from defects in leptin production. Consistent with the
postulated role of leptin in communicating body fat de-mately 19 weeks of age (between 132 and 138 days).
As shown in Figure 3, MC4-R–deficient mice are signifi- pot contents to the brain (Campfield et al., 1995; Halaas
et al., 1995; Pelleymounter et al., 1995; Campfield et al.,cantly longer than wild-type controls. The mean length
of homozygous mutant females is increased approxi- 1996), leptin is also elevated in MC4-R–deficient mice
(Figures 5E and 5F). At 4–8 weeks of age, leptin wasmately 11% relative to wild-type F2 mice, and hetero-
zygous females are approximately 7% longer than elevated 4.5-fold and 1.5-fold in the serum of female
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Figure 2. Weight Gain of MC4-R–Deficient Mice and Control Littermates
Each line represents the weight gain of an individual mouse.
(A) Weight gain of female homozygous (2/2) mutant mice (closed squares) and wild-type (1/1) F2 controls (open circles). The weights of 9
homozygous and 12 control mice were taken at the times indicated.
(B) Weight gain of female heterozygous (1/2) mutant mice (x) and wild-type (1/1) F2 controls (open circles). The weights of 18 heterozygous
and 12 control mice were taken at the times indicated.
(C) Weight gain of male homozygous (2/2) mutant mice (closed squares) and wild-type (1/1) F2 controls (open circles). The weights of 9
homozygous and 17 control mice were taken at the times indicated.
(D) Weight gain of male heterozygous (1/2) mutant mice (x) and wild-type (1/1) F2 controls (open circles). The weights of 18 heterozygous
and 17 control mice were taken at the times indicated.
and male homozygous mutants, respectively, relative to MC4-R gene knockout on basal corticosterone levels
was detected.wild-type controls. By 17–23 weeks of age serum leptin
levels in females had reached approximately 97 ng/ml,
in males approximately 58 ng/ml, representing increases POMC Gene Expression
To assess whether the observed effects of MC4-R dele-of 6.5- and 2.5-fold, respectively. Heterozygous mice,
for the most part, showed leptin levels intermediate be- tion on weight homeostasis could be attributed to the
induction of compensatory changes in expression of thetween that observed for wild-type mice and homozy-
gous mutants. sole known source of ligand for the MC4-R, the POMC
gene, central POMC gene expression was examined inSince glucocorticoids can profoundly affect weight
homeostasis and somatic growth, basal serum cortico- wild-type mice, mice heterozygous for MC4-R deletion,
and homozygous mutants by in situ hybridization (Fig-sterone was measured in three sets of sex-matched
littermates, each containing a wild-type, heterozygous, ures 7D–7F). No new sites of POMC gene expression
and no consistent change in the levels of POMC mRNAand homozygous mutant animal (Figure 6). No effect of
Deletion of the MC4 Receptor Results in Obesity
135
Figure 4. Mice Lacking the MC4-R Are Hyperphagic
The food intake of female mice housed in pairs was measured every
Figure 3. Increased Linear Growth of MC4-R–Deficient Mice weekday over a two-week period. The open bars represent the mean
The body length of female (open bars) and male (hatched bars) was of eight measurements on one cage each of two Ay and two control
measured at approximately 19 weeks of age (between 132 and 138 C57BL/6 mice, at 9 weeks of age. The hatched bars represent the
days). The bars indicate the mean length of 12 wild-type (1/1), 14 mean of eight measurements on each of two cages of two homozy-
heterozygous (1/2), and 9 homozygous mutant (2/2) female F2 gous mutant mice (2/2) and two F2 wild-type controls (1/1). Two
mice, and 15 wild-type, 20 heterozygous, and 9 homozygous mutant of each of the mutant mice and F2 controls were 15 weeks of age;
male F2 mice. Error bars represent the standard error of the mean, the remaining two of both genotypes were each 17.5 and 20.5 weeks
and the asterisks denote significant difference (p , 0.02 by two- of age. Error bars represent the standard error of the mean, and
tailed Student t test) compared to the wild-type value within a similar the asterisks denote significant difference (p , 0.01 by two-tailed
sex. Student t test) of either Ay compared to C57BL/6 or MC4-R 2/2
homozygous mutants compared to MC4-R 1/1 wild-type F2 mice.
in its primary site of expression, the arcuate nucleus
of the hypothalamus, were detected by this assay. In contact with neurons from the hypothalamic arcuate
nucleus and the nucleus of the solitary tract of theaddition, no gross neuroanatomical defects were ob-
served in thionin-stained brain sections from heterozy- brain stem, the primary sites of expression in the brain
of POMC (Jacobowitz and O’Donohue, 1978; Wat-gous or homozygous mutant MC4-R–deficient animals
by histological analysis (Figures 7A–7C). son et al., 1978). Melanocortin peptides derived from
processing of POMC, including adrenocorticotrophin
(ACTH) and the a-, b- and g-melanocyte–stimulating hor-Discussion
mones (a, b, g MSH) (reviewed in O’Donohue, 1982), are
the sole known ligands for the melanocortin receptors.In this study, we have generated mice lacking expres-
sion of the MC4-R by gene targeting, and we report The observed loss of weight regulation in mice lacking
the MC4-R implies an inhibitory role of MC4-R ligand(s)that a maturity onset obesity syndrome associated with
hyperphagia, hyperinsulinemia, and hyperglycemia oc- in body energy balance and metabolism. This is further
supported by recent pharmacological studies of the cy-curs in the absence of the receptor. This syndrome is
quite distinct from that elicited by mutations of the ob clic melanocortin analogues, MTII and SHU9119, a high
affinity agonist and antagonist, respectively, of bothand db loci, in which the inability to produce leptin (ob/
ob) or respond to it (db/db) results in an early-onset neural melanocortin receptors MC3 and MC4 (Hruby et
al., 1995). Intracerebroventricular (ICV) injection of theobesity and extreme hyperphagia and hyperinsulinemia.
In addition, in ob and db mice, basal- and stress-acti- agonist MTII in four models of hyperphagia (ob mice,
fasted C57BL/6J mice, Ay mice, and mice coinjectedvated corticosterone levels are significantly elevated
(Dubuc et al., 1975; Coleman and Burkart, 1977), and with NPY) suppressed feeding in a dose-dependent
manner, and this suppression could be prevented byadrenalectomy dramatically decreases obesity (Solo-
mon and Mayer, 1973), whereas no effect on basal corti- coinjection of the antagonist SHU9119 (Fan et al., 1997).
Furthermore, injection of the antagonist produced a sig-costerone was detected in MC4-R–deficient mice. Fur-
thermore, whereas ob and db mice are shorter than their nificant increase in food intake. Together with the data
presented here, these results demonstrate a novel rolewild-type littermates (Heston and Vlahakis, 1962; Wolff,
1963), mice lacking the MC4-R display increased linear for melanocortinergic neurons in tonic inhibition of feed-
ing and metabolism. The increased somatic growth ob-growth.
Consistent with a role in body weight regulation, the served in MC4-R–deficient mice also suggests involve-
ment of neurons expressing MC4 receptors in regulationMC4-R is expressed in a number of hypothalamic sites,
including the ventromedial, lateral, dorsomedial, and of growth hormone–releasing hormone.
Expression of melanocortin peptides in the brain haveparaventricular nuclei (Mountjoy et al., 1994), which play
an important role in regulating feeding behavior (re- previously been implicated in a number of other biologi-
cal activities, including increasing retention of learnedviewed in Bray,1987). These neurons are also in synaptic
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Figure 5. Serum Glucose, Insulin, and Leptin
Levels in Mice Lacking the MC4-R
Glucose, insulin, and leptin were each mea-
sured on the same serum samples. Open bars
represent mean values for wild-type F2 con-
trols, hatched bars represent heterozygotes,
and shaded bars represent homozygous mu-
tant mice. Error bars indicate the standard
error of the mean. Asterisks denote signifi-
cant difference (p , 0.05 by two-tailed Stu-
dent t test) compared to control within the
same sex and age group. For female mice,
the n for wild-type mice at 4–8 weeks, 10–14
weeks, and 17–23 weeks was 11, 14, and 7,
respectively; for heterozygotes, 17, 17, and
7, respectively; and for homozygous mutants,
7, 11, and 3, respectively. For male mice, the
n for wild-type mice at 4–8 weeks, 10–14
weeks, and 17–23 weeks was 14, 14, and 6,
respectively; for heterozygotes, 14, 14, and
5, respectively; and for homozygous mutants,
8, 8, and 9, respectively.
(A and B). Serum glucose levels of female and
male mice, respectively. Five ml of serum was
analyzed using a glucose oxidase assay.
(C and D). Serum insulin levels of female and
male mice, respectively, were assayed by ra-
dioimmunoasay using rat insulin as the
standard.
(E and F). Serum leptin levels of female and
male mice, respectively, were measured by
radioimmunoassay.
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and rodents are associated with obesity (reviewed in
Bray, 1984). This argument is formally difficult to ex-
clude; however, no gross neuroanatomical defects were
observed in brain sections from mice lacking the MC4
receptor. Furthermore, direct evidence for a pharmaco-
logical etiology is provided by the modulation of feeding
behavior affected by the cyclic melanocortin analogues,
MTII and SHU9119, as described above. In addition, the
MC4-R–deficient obesity phenotype is strikingly similar
to the agouti obesity syndrome, consistent with a spe-
cific common mode of action of the two mutations (i.e.
interference with MC4-R signaling) rather than a devel-
opmental defect in MC4-R–deficient mice.
The agouti protein is a pigmentation factor normally
expressed in the skin where it regulates the synthesis of
Figure 6. MC4-R Gene Deletion Does Not Affect Basal Serum Corti- pigment by antagonism of the MC1-R on melanocytes.
costerone Dominant mutations of the agouti locus that result in
Serum corticosterone levels were measured in three sets of sex- widespread ectopic expression give rise to the pleiotro-
matched littermates containing a representative animal of each ge- pic agouti obesity syndrome (Bultman et al., 1992; Mi-
notype: 1/1 wild-type control, 1/2 heterozygote, 2/2 homozygous
chaud et al., 1993; Miller et al., 1993; Duhl et al., 1994;mutant. Sets are, from left to right, male, female, and male. Males
Michaud et al., 1994a; 1994b). The demonstration thatwere 15 weeks of age, females were 18 weeks. Data indicate the
agouti in vitro is a competitive antagonist of not onlymeans of measurements performed using two serum samples ob-
tained on different days. Measurement on each day was performed the melanocyte MC1-R but also the neural MC4-R led
in duplicate. Bars indicate standard deviation. Analysis of data by to the hypothesis that agouti induces obesity by chronic
two-way ANOVA indicated no significant difference in corticoste- antagonism of the MC4-R (Lu et al., 1994). In this study
rone levels as a function of genotype.
we have observed noteworthy similarities between the
MC4-R–deficient and agouti obesity syndromes. Mice
behaviors (Murphy and Miller, 1955; DeWied and Jolles, lacking the MC4-R develop obesity and hyperinsulin-
1982), antipyresis and regulation of temperature control emia with a time course very similar to that described
(Lipton and Glyn, 1980; Murphy et al., 1983; Feng et for Ay and Avy mice (Dickie and Woolley, 1946; Dickerson
al., 1987), elevation of heart rate, blood pressure, and and Gowen, 1947; Yen et al., 1976a; Frigeri et al., 1983;
natriuresis (Klein et al., 1985; Lin et al., 1987). The Warbritton et al., 1994; reviewed in Yen et al., 1994).
involvement of MC4-R–dependent signaling in mediat- The MC4-R–mutant mice also exhibit increased linear
ing these various biological effects can now be ad- growth, a feature unique to the agouti syndrome among
dressed in mice lacking expression of the receptor. rodent obesity models. Furthermore, as is also the case
An alternative to the conclusion that signaling by the for the agouti obesity syndrome, the obesity of MC4-
MC4-R directly influences feeding and metabolism is R–deficient mice is not dependent on elevation of basal
that MC4-R gene deletion could result in a defect in adrenocortical steroids (Wolff and Flack, 1971). Analysis
hypothalamic brain development resulting in hyperpha- of the expression of neuropeptide Y (NPY, a potent stim-
gia and hypometabolism. For example, defects in func- ulator of feeding) in Ay and MC4-R–deficient mice has
uncovered a further common and unique feature of thetioning of the ventromedial hypothalamus in humans
Figure 7. MC4-R Gene Deletion Does Not Affect Brain POMC mRNA Levels
(A–C) Thionin-stained brain sections from wild-type, heterozygous, and homozygous mutant MC4-R–deficient mice, respectively.
(D–F) Autoradiographs of brain sections from wild-type, heterozygous, and homozygous mutant MC4-R–deficient mice, respectively, hybridized
with a 35S-POMC antisense cRNA probe.
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two melanocortinergic obesity models (R. C. and R. K., 1994b). Although agouti is a secreted protein, it acts in
personal communication). NPY expression was un- a localized fashion and does not appear to circulate at
changed in the arcuate nucleus, but dramatically ele- significant levels (Wolff, 1963; Silvers, 1979). Thus, the
vated in the dorsal medial hypothalamic (DMH) nucleus relevant concentration of agouti for mediating antago-
in both obese Ay and MC4-R–deficient mice. Elevation nism of the MC4-R is likely that which is expressed in
of NPY in the arcuate nucleus is found in several obesity the immediate milieu of the receptor in the brain.
models, including ob mice (Sanacora et al., 1990; Ste- Targeted deletion of the MC4-R has revealed a novel
phens et al., 1995; Schwartz et al., 1996), but expression signaling pathway in the brain controlling nutrient in-
of NPY in the DMH has not previously been reported in take and energy balance. Further analysis of the regula-
association with obesity. This finding shows a common tion and consequences of melanocortinergic signaling
change in hypothalamic gene expression in the agouti- should prove instructive in the elucidation of the physio-
and MC4-R–deficient mice, and may imply involvement logical control of body weight and may provide novel
of the DMH in the melanocortinergic obesity syndrome. therapies for treatment of obesity.The obesity syndrome
The striking recapitulation of many features of the resulting from abrogation of MC4-R signaling convinc-
agouti obesity syndrome in MC4-R–deficient mice ingly mirrors that generated by ectopic agouti expres-
strongly supports the conclusion that the syndrome de- sion, demonstrating central antagonism of melanocortin
rives from agouti-mediated disruption of an MC4-R– signaling via the MC4-R as the primary cause of the
dependent signaling pathway involved in the regulation agouti obesity syndrome.
of body weight. Our data are not consistent with an
alternative hypothesis that the primary site of agouti
Experimental Proceduresaction in eliciting the obesity syndrome is peripheral,
mediated by elevation of intracellular levels of free cal-
Construction of the MC4-R Targeting Vector
cium in skeletal muscle (Zemel et al., 1995) and/or adipo- Murine MC4-R gene sequences were isolated from a mouse strain
cytes and pancreatic b-cells (Klebig et al., 1995; Manne 129/Sv genomic phage library (Stratagene) using a probe generated
et al., 1995). Those phenotypic differences we have de- by PCR amplification of human MC4-R coding sequences.
Construction of the MC4-R targeting construct was carried outtected between mice lacking the MC4-R and dominant
in the vector pJN2 that was produced in the following manner.agouti mutants have been quantitative rather than quali-
The 1.4 kb EcoRI–AvaI fragment of pBR322 was replaced with thetative. For example, the absolute weight gain of MC4-R
synthetic oligonucleotides AAT TAG CGG CCG CAG TAT GCA AAAmutants appears to be greater than that of agouti mu-
AAA AGC CCG CTC ATT AGG CGG GCT and CCG AAG CCC GCC
tants. Keeping in mind that there are considerable varia- TAA TGA GCG GGC TTT TTT TTG CAT ACT GCG GCC GCT. The
tions in the weight of obese yellow mice on different resulting plasmid, pJN1, was digested with NotI, and the following
genetic backgrounds and there is no data for body oligonucleotides were ligated into the NotI site to generate pJN2:
GGC CGG CAT GCA TCA AGC TTA TCT CGA GAT CGT CGA CTAweight of dominant agouti mutants on the 129/Sv 3
CCA TGG TAC ATC GAT CAG GTA CCA TCC CGG GGC and GGCC57BL/6 background of the MC4-R–deficient mice, this
CGC CCC GGG ATG GTA CCT GAT CGA TGT ACC ATG GTA GTCweight increase tends to be higher than that reported
GAC GAT CTC GAG ATA AGC TTG ATG CAT GCC.for age and sex-matched Ay or Avy mice on a variety of
A 1.2 kb genomic fragment extending from the HindIII site located
backgrounds (Castle, 1941; Dickie and Woolley, 1946; approximately 0.6 kb 39 of the MC4-R gene to the SphI site located
Dickerson and Gowen, 1947; Carpenter and Mayer, approximately 1.8 kb 39 of the MC4-R gene, representing the 39
1958; Yen et al., 1976a; Yen et al., 1976b; Frigeri et al., region of genomic homology, was subcloned into SphI–HindIII–
digested pJN2. A 3.4 kb genomic fragment extending from the NcoI1983; Wolff, 1987; Frigeri et al., 1988). Similarly, the levels
site located at the 59 end of the MC4-R gene to the HindIII siteof serum insulin in both males and females homozygous
located approximately 3.4 kb 59 of the gene, representing the 59for MC4-R deletion, as well as glucose levels in MC4-
region of genomic homology, was also ligated into this plasmid, 59R–deficient males, are higher than those reported for
of the 1.2 kb HindIII–SphI fragment, and in the same orientation.
age- and sex-matched Avy mice (Frigeri et al., 1983). The PGK–neo expression cassette from the plasmid pKJ1 (Tybu-
Lastly, inactivation of the MC4-R results in a greater lewicz et al. 1991), containing the neo gene under the transcriptional
increase in the length of mice than that observed as control of the mouse phosphoglycerate kinase (PGK-1) promoter
and the PGK-1 poly(A) addition site, was ligated between the 59 anda result of ectopic expression of agouti (Castle, 1941;
39 fragments of MC4-R genomic homology to generate the MC4-RCarpenter and Mayer, 1958). These differences may re-
targeting vector. The vector was linearized with NotI digestion priorflect a dose dependency of MC4-R antagonism on the
to electroporation.
severity of the obesity syndrome, with deletion of the
receptor equivalent to absolute antagonism as opposed
ES Cell Transfectionto less complete antagonism of the receptor by ectopic
The RF-8 ES cell line (Huang et al., 1996) was cultured on SNL76/7agouti expression. This model is supported by 1) data
mitotically inactive feeder cells. For electroporation, cells were tryp-
reported here of a gene dosage effect of heterozygosity sinized and resuspended at a concentration of 1.1 3 107/ml in PBS
for receptor deletion on the extent of obesity, hyperinsu- (Ca21- and Mg21-free; Gibco). A 0.9 ml aliquot (1 3 107 cells) was
linemia, hyperglycemia, and linear growth; by 2) the ob- mixed with 20 mg of the linearized targeting vector and pulsed at
servation that the level of ectopic agouti expression in 250V, 500 mF (Bio-Rad Gene Pulser). The cells were then diluted in
culture medium, plated at 1–2 3 106 per 100mm plate containingagouti transgenics correlates with the severity of obe-
feeder cells, and placed under selection 24 hr later in G418 sulfatesity, hyperinsulinemia and hyperglycemia (Klebig et al.,
(400 mg/ml powder, Gibco). G418-resistant clones were picked, dis-1995; Perry et al., 1995); and by 3) dominant agouti
sociated with trypsin, and divided into one well each of two 96-well
mutations resulting from intracisternal A particle (IAP) plates. Upon confluence, ES cells were frozen in one of the 96-well
insertions in which expressivity of the obese phenotype plates as described (Ramirez-Solis et al., 1993) and expanded into
is positively correlated with the levels of agouti expres- a 24-well plate from which DNA was prepared, upon confluence,
for Southern blot analysis.sion (Wolff et al., 1986; Duhl et al., 1994; Michaud et al.,
Deletion of the MC4 Receptor Results in Obesity
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Southern Blot Hybridization Histology
For in situ hybridization analysis of POMC gene expression, wild-Genomic DNA was prepared in situ from ES cells in 24-well plates
and from tailbiopsies by the procedureof Laird etal. (1991). Approxi- type heterozygous, and homozygous mutant mice were maintained
under a 12 hr light, 12 hr dark cycle at constant temperature. Foodmately 20 mg of genomic DNA was digested with the indicated
restriction endonuclease, electrophoresed through a 1% agarose (Purina mouse chow) and water were provided ad libitum. Anesthe-
tized (avertin) animals were sacrificed between 1500 and 1700 hr,gel, transferred to Hybond N1 membrane (Amersham), and hybrid-
ized with the 32P-radiolabeled probes indicated in the text. before lights out via cardiac puncture and perfusion with saline (20
ml) and then 50 ml of ice-cold fixation buffer (4% paraformaldehyde
in borate buffer [pH 9.5]). Whole brains were rapidly removed andGeneration of MC4-R–Deficient Mice
then postfixed overnight in 10% sucrose/fixative buffer. BlockedThe targeted ES clone was injected into C57BL/6J blastocysts as
hypothalamic sections were frozen in powdered dry ice and thendescribed (Bradley, 1987) to generate chimeras. Male chimeras were
stored at 2808C prior to sectioning.bred with C57BL/6J females, and agouti offspring (representing
Antisense POMC probe was prepared by linearizing the plasmidgermline transmission of the ES genome) were screened for the
mPOMCE3ribo (kindly provided by Dr. Malcolm Low), containingpresence of thetargeted MC4-R gene by Southern blot hybridization
exon 3 of the mouse POMC gene, with NcoI. [35S] cRNA probesof ApaI- and NcoI-digested tail DNA with the flanking probe shown
were prepared by transcribing 1 mg of each linearized DNA with T7in Figure 1A. Offspring heterozygous for the mutation were bred
DNA polymerase for 1 hr at 378C as described (Promega). Hypothala-together, and mice homozygous for the MC4-R deletion were identi-
mic brain blocks were mounted on a frozen stage and serially sec-fied by Southern blot hybridization of ApaI- or NcoI-digested tail
tioned into 4 series of 20 mM slices with a sliding microtome. Sec-DNA with the flanking probe.
tions were prepared and hybridized as previously described (Arriza
et al., 1988). Sections were hybridized for 20 hr at 588C with 35S-Weight and Length Measurements
labeled probes (5 3 106 cpm/ml) in 65% formamide, 0.26 M NaCl,Weight gain was regularly measured, beginning at 3–4 weeks of age,
1.33 Denhardt’s solution, 1.3 mM EDTA, 13% dextran sulfate, andusing a Sartorius model #14800 P balance. Length was measured by
13 mM Tris (pH 8). Sections were then digested with RNase (20 mg/manual immobilization and extension of the mouse to its full length,
ml) for 30 min at 378C and then desalted in a series of washes fromalways by the same individual, and measurement of the nose-to-
43 SSC/1mM DTT to a final stringency of 0.13 SSC/1mM DTT atanus distance in centimeters.
658C for 30 min. Sections were dehydrated in ascending ethanol,
vacuum dried at room temperature for 30 min, and then exposed toFood Consumption
Dupont Cronex film for several days. Dried slides were thendipped inFood intake was measured for two Ay, two C57BL/6J, four MC4-R
NTB-2 emulsion (Kodak) and developed after 6 days.homozygous mutants, and four wild-type F2 controls, each housed
two to a cage. The mice were housed for at least a week before
any measurements were taken. Over a two-week period, a sufficient Acknowledgments
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